Polarean Imaging (POLX) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Polarean Imaging

NOTE: This is based on 15 open tips for Polarean Imaging (POLX)


Polarean Imaging (POLX)
Latest Quote Price

0.11p

Polarean Imaging (POLX)
Price Change (%)

-5.56%


Latest Bid : 0.10p Latest Ask : 0.14p
High Today : 0.14p Low Today : 0.11p
This Years High : 1.50p This Years Low : 0.08p
Volume : 800,000 MKT Cap : £1.69M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Polarean Imaging (POLX) Overview

Polarean is a clinical-stage company with a core technology that is a drug-device combination product that enables the visualisation of hyperpolarised 129Xe ("HPX") using MRI technology to help diagnose lung disease earlier, identify the type of intervention likely to benefit a patient, and to monitor the efficacy of treatment. It is currently being used at a number of research sites on a pre-FDA clearance basis to facilitate the research and evaluation of lung function, to assist in making improved disease progression assessment and to clearly visualise the effectiveness of several therapeutics which are under development.

Polarean Imaging (POLX) Latest Tips

Type Tipster SectorScore Start date Performance
Sell Steve Moore Premium Only 2025-12-01 13:50:00 01/12/2025 -27.27%
Sell Steve Moore Premium Only 2025-11-14 14:15:00 14/11/2025 -40.00%
Avoid Steve Moore Premium Only 2025-10-22 11:15:00 22/10/2025 22.22%
Avoid Steve Moore Premium Only 2024-05-22 11:00:00 22/05/2024 89.23%
Avoid Steve Moore Premium Only 2023-09-07 11:40:00 07/09/2023 98.73%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Polarean Imaging (POLX) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 0.10p Latest Ask : 0.14p
High Today : 0.14p Low Today : 0.11p
This Years High : 1.50p This Years Low : 0.08p
Volume : 800,000 MKT Cap : £1.69M

Polarean Imaging Overview

Polarean is a clinical-stage company with a core technology that is a drug-device combination product that enables the visualisation of hyperpolarised 129Xe ("HPX") using MRI technology to help diagnose lung disease earlier, identify the type of intervention likely to benefit a patient, and to monitor the efficacy of treatment. It is currently being used at a number of research sites on a pre-FDA clearance basis to facilitate the research and evaluation of lung function, to assist in making improved disease progression assessment and to clearly visualise the effectiveness of several therapeutics which are under development.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Polarean Imaging Tips

Type Tipster SectorScore Start date Performance
Sell Steve Moore Premium Only 2025-12-01 13:50:00 01/12/2025 -27.27%
Sell Steve Moore Premium Only 2025-11-14 14:15:00 14/11/2025 -40.00%
Avoid Steve Moore Premium Only 2025-10-22 11:15:00 22/10/2025 22.22%
Avoid Steve Moore Premium Only 2024-05-22 11:00:00 22/05/2024 89.23%
Avoid Steve Moore Premium Only 2023-09-07 11:40:00 07/09/2023 98.73%